Skip to content
Screener

MiniMed Group MMED Total Revenue

Total Revenue at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$39K+388%
Marriott International logo
Marriott InternationalMAR
$1.4B+12.1%
Biogen logo
BiogenBIIB
$963.3M-13.0%
PTH
Pelthos TherapeuticsPTHS
$10.67M
Life Time Group Holdings logo
Life Time Group HoldingsLTH
$837.4M+13.8%
iRadimed logo
iRadimedIRMD
$15.39M+18.7%

Segments

By product

See full
CGM$390M+18.2%
Consumables$244M+14.6%
Pumps$151M+11.0%

By geography

See full
International$548M+20.2%

Other financials

Income statement

See full
Gross profit$362.0M-8.4%
Operating income-$100.0M-576%
Net income-$119.0M-1,090%
EPS (diluted)-$0.47-1,075%

Balance sheet

See full
Cash & equivalents$298.0M+2,609%
Total debt$53.0M-20.9%
Total equity$3.6B+8.4%
Total assets$4.6B+10.2%

Cash flow

See full
Operating cash flow-$27.0M-147%
CapEx$167.0M+22.8%
Free cash flow-$194.0M-146%

Valuation

See full
Market cap$5.17B+2.3%
Enterprise value$4.93B
P/S1.9×

Profitability

See full
Gross margin54.4%
Operating margin-4.2%
Net margin-11.9%
FCF margin-12%

Returns & leverage

See full
Return on equity-9.3%
Debt / equity
Current ratio1.6×

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: MiniMed Group’s 10-Q, filed April 17, 2026.

Filed
Apr 17, 2026, 4:29 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-025777
(in millions, except share and per share data)Three Months Ended / January 23, 2026Three Months Ended / January 24, 2025Nine Months Ended / January 23, 2026Nine Months Ended / January 24, 2025
Net sales$790$687$2,265$1,991
Cost of products sold4282921,065869
Gross Profit3623951,2001,123
Operating expenses:
Research and development expense114112349329
Selling, general, and administrative expense309268884804
Certain litigation charges, net(6)11
Other operating expense (income), net45(7)53(12)

Item 1. Financial Statements (

FAQ

What is MiniMed Group's total revenue?
MiniMed Group (MMED) reported total revenue of $790M in Q1 2026.
How has MiniMed Group's total revenue changed year-over-year?
MiniMed Group's total revenue increased by 15.0% year-over-year, from $687M to $790M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about MiniMed Group's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude